Breast cancer is the most prevalent malignant tumor and main oncologic cause of mortality
in women. Although most diagnosis of breast pathology is accomplished using hematoxylin …

Although there have been several studies on the use of immunohistochemical biomarkers of
canine mammary tumors (CMTs), the results are difficult to compare. This article provides …

Widely recognized as the gold standard reference in the field, Rosen's Breast Pathology
provides comprehensive, up-to-date information on diseases of the breast from renowned …

In the 4th edition of the WHO Classification of Tumours of the Breast, myoepithelial lesions
are retitled myoepithelial and epithelial–myoepithelial lesions in order to better reflect the …

We describe a preclinical model that investigates progression of early-stage ductal
carcinoma in situ (DCIS) and report that compromised myoepithelial cell differentiation …

Breast cancer is an individually unique, multi-faceted and chameleonic disease, an eternal
challenge for the new era of high-integrated precision diagnostic and personalized …

Cancer-associated stroma (CAS) is widely recognized to influence development and
progression of epithelial tumours including breast cancer. Canine mammary tumours …

Context Immunohistochemistry is a valuable tool in routine breast pathology, used for both
diagnostic and prognostic parameters. The diagnostic immunomarkers are the scope of this …

Adenomyoepithelioma of the breast is an uncommon tumor characterized by dual
differentiation into luminal cells and myoepithelial cells. A spectrum of histologic patterns is …

Ductal carcinoma in situ (DCIS) is a non-obligate precursor of invasive ductal carcinoma
(IDC), whereby if left untreated, approximately 12% of patients develop invasive disease …